The design of gene delivery systems based on PAMAM derivative as carrier and their transfection mech

来源 :第一届《药学学报》药学前沿论坛暨2015年中国药学会中药与天然药物专业委员会会议 | 被引量 : 0次 | 上传用户:China_BILLGATES
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  Gene transfer vector is one of the key technologies of gene therapy.Gene carriers generally can be divided into two major categories of virus and non-virus,the former is subjected to security challenges.The latter much favored in medical science and also is currently the main object of pharmaceutical research because of its safety,vector design diversity and low cost.In non-virus carrier,polycation gene carrier due to the high rate of transfection and become a main research subject.Polyamidoamine(PAMAM)is one of the important member in the family of cationic polymer carrier,PAMAM dentrimers are attracted highly attention recently due to their special properties in the drug and gene delivery systems,especially the high generation PAMAM as the gene vector shows strength transfection ability compared with the other non-viral carrier materials.The main drawback for the materials is presenting serious cell toxicity.In order to overcome this problem,one new gene delivery system has been designed by our research group.This is that PAMAMs are covalently conjugated onto α-cyclodextrin(α-CD)via amide bonds to obtain the starburst-like cationic polymers(CD-PG2).The chemical structure and composition of CD-PG2 was characterized by H-NMR.The physicochemical and biological properties of CD-PG2/pDNApolyplex were evaluated by agarose gel retardation,stability test against DNaseⅠ,MTT assay,DLS measurement,CLSM observation,LDH leakage test,and in vitro cell transfection.The test results tell us that the CD-PG2 could efficiently condense pDNA into nano-scale particles with a narrow size distribution,and protest from DNaseⅠ degradation.CD-PG2 shows excellent gene transfection efficiency without serum interference as well as relatively low cytotoxicity,compared with free PET-25K and commercial product Lipofectamine 2000(one good gene vector).The cell uptake route analysis shows cellular uptake CD-PG2/pDNApolyplex is mainly through Clathrin-mediated endocytosis,CME and Caveolae-mediated endocytosis,CvME route and further investigations demonstrate that α-CD could regulate CvME pathway to improve polyplex transfection behavior.
其他文献
目的:分析铅暴露大鼠海马组织差异表达的蛋白质,以探讨铅暴露致大鼠海马组织损伤的作用机制.方法:健康雄性SPF级F34大鼠40只,随机分为对照组和铅暴露组,釆用自由饮水的方式染毒,醋酸铅组给予0.03%醋酸铅饮水,对照组给予0.03%醋酸钠饮水,连续染毒9周,提取大鼠海马组织总蛋白,采用同位素标记iTRAQ技术结合高效液相色谱一电喷雾串联质谱(LC-ESI-MS/MS)的定量蛋白质组学方法,分析和鉴
为了实现国家基本公共卫生服务均等化的目标,以便更有效地向群众提供卫生服务,满足居民的公共卫生服务需求,本文通过文献研究总结了社区公共卫生服务的提供模式,主要有政府直接提供和政府购买的模式.属于政府直接提供服务的形式有医防合一、医防分设、依院设所、县乡垂直等;属于政府购买的形式有合同承包/出租、凭单制度、公共卫生服务券、定额补助等.中国目前在社区公共卫生服务提供模式的实践上,主要有以家庭医生责任制为
[目的]评估出生前后氯酚暴露对3岁儿童体格发育的影响.[方法]收集377母子问卷信息和随机尿样,气相色谱-串联质谱法(GCMS/MS)检测尿中2,4-二氯酚(2,4-DCP)、2,5-二氯酚(2,4-DCP)、2,4,5-三氯酚(2,4,5-TCP)、2,4,6-三氯酚(2,4,6-TCP)和五氯酚(PCP)含量.测量三岁儿童体重、身高和头围等体格指标,并根据世界卫生组织儿童生长发育参考值计算Z评
AIM:Diabetic enteropathy(DE),a common complication of diabetes mellitus(DM),is drawing a growing attention worldwide.MEK/ERK pathway is a classic pathway associated with cell proliferation and differe
会议
病例介绍中年男性,48岁,大学文化,总经理病史2年.因心绞痛看病,发现前降支闭塞,拟行支架植入术未成功,行CABG治疗,一年后桥血管闭塞,再次拟行PCI治疗,未成功,目前有劳力型心绞痛.既往史:高血压病史10余年,血压控制正常,血糖正常,戒烟,戒酒.超声心动图:左室内径正常,LVEF 58 %,左室前壁室间隔下段和心尖部运动减弱
会议
多药耐药性(multidrug resistance,MDR)是肿瘤成功化疗的主要障碍.ABC 转运泵如ABCB1、ABCC1、ABCG2 过表达是介导MDR 的主要原因.目前,仍没有MDR 的逆转剂用于临床.靶点药物如酪氨酸激酶抑制剂(tyrosine kinase inhibitors,TKIs)在肿瘤治疗中起重要作用,但TKI与传统抗癌药物少有协同作用.由于TKI与传统抗癌药物主要毒副作用不
考察微透析不同灌流液取样对大鼠海马神经递质的影响,为靶器官的药代动力学和药效动力学研究提供方法.优化已建立的检测微透析样品中去甲肾上腺素(NE)、肾上腺素(EP)、多巴胺(DA)、3,4 二羟基苯乙酸(DOPAC)、5-羟色氨(5-HT)、5-羟吲哚乙酸(5-HIAA)和高香草酸(HVA)等的高效液相-电化学(HPLC-ECD)分析方法,工作电压设为0.60 V.选取Wistar 大鼠5 只,右侧
环糊精在增加药物溶解性、生物利用度和实现药物靶向输送等方面具有独特优势.环糊精超分子给药系统中,药物从环糊精超分子中解离的动力学常数koff,决定药物释放、吸收的分子机制.对于难溶性药物koff的测定,表面等离子共振和荧光光谱技术存在效率与成本方面的局限性.研究将“考虑药物-受体结合动力学行为”的药物发现新理念运用到超分子给药系统评价,发展了表征超分子解离的koff高效液相亲和色谱(high pe
The industrial chain of traditional Chinese medicine(TCM)is a complicated process including multiple links.Its very difficult to ensure the quality to be safe,effective,stable and controllable in each
用药效和毒理实验证明为最佳组方和恒定化学组成的中药制剂(原料)可作标准(对照)制剂(SP):指标含量应±5%,Sm≥0.95和95%≤Pm≤105%,据此可在不同时间段重新获得SP.采用随行法测定2 次SP 指纹图谱以均值法建立对照指纹图谱;同法测定2次样品指纹图谱,采用系统指纹定量法并用《中药色谱指纹图谱超信息特征数字化评价系统》4.0 软件按并联指纹图谱评价样品宏定性Sm、宏定量Pm相似度,能